NCT05774548 LA PrEP Impact and Cost-effectiveness (TEAMS)
| NCT ID | NCT05774548 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | Hiv |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,720 participants |
| Start Date | 2022-03-15 |
| Primary Completion | 2026-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,720 participants in total. It began in 2022-03-15 with a primary completion date of 2026-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will have three components: 1. Discrete choice experiments 2. Analysis of routine service data 3. Impact and cost-effectiveness analyses using results from 1 and 2
Eligibility Criteria
Inclusion Criteria: * Minimum age of 18 years * Individual assigned male at birth reporting sex with men in the past 12 months * Self-reported HIV-negative MSM and TGW who either report interest in PrEP use, current PrEP use, or past PrEP use * Permit audio recording during the interview and/or discussion. Exclusion Criteria: * Not willing to participate in the study
Contact & Investigator
Nittaya Phanuphak, MD,PhD.
PRINCIPAL INVESTIGATOR
INSTITUTE OF HIV RESEARCH AND INNOVATION FOUNDATION
Frequently Asked Questions
Who can join the NCT05774548 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Hiv. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05774548 currently recruiting?
Yes, NCT05774548 is actively recruiting participants. Contact the research team at nittaya.p@ihri.org for enrollment information.
Where is the NCT05774548 trial being conducted?
This trial is being conducted at Bangkok, Thailand, Bangkok, Thailand, Bang Lamung, Thailand, Chon Buri, Thailand and 8 additional locations.
Who is sponsoring the NCT05774548 clinical trial?
NCT05774548 is sponsored by Institute of HIV Research and Innovation Foundation, Thailand. The principal investigator is Nittaya Phanuphak, MD,PhD. at INSTITUTE OF HIV RESEARCH AND INNOVATION FOUNDATION. The trial plans to enroll 10,720 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.